News
03-25-2011, 05:33 AM
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.
More... (http://www.news-medical.net/news/20110325/Positive-Phase-3-results-from-Tarsas-ORACAL-study-validates-Unigenes-oral-peptide-drug-delivery-technology.aspx)
More... (http://www.news-medical.net/news/20110325/Positive-Phase-3-results-from-Tarsas-ORACAL-study-validates-Unigenes-oral-peptide-drug-delivery-technology.aspx)